Hadwen Arboretum

Eurofins CDMO Alphora Inc. (Canada) Announces the Launch of its Biologics Initiative focusing on mAbs and Therapeutic Proteins

Retrieved on: 
Wednesday, October 4, 2023
Science, Other Science, Biotechnology, Pharmaceutical, Medical Supplies, Health, Infectious Diseases, Other Health, Therapy, Quality by design, OTF, Bioprocess engineering, Hook effect, API, Design of experiments, Hadwen Arboretum, Documentation, Biopharmaceutical, CGMP, Map, Doe, Safety, Fine chemical

Eurofins CDMO Alphora Inc. is pleased to announce the launch of its Biologics initiative, as part of its vision to diversify and grow within the contract development and manufacturing industry in North America.

Key Points: 
  • Eurofins CDMO Alphora Inc. is pleased to announce the launch of its Biologics initiative, as part of its vision to diversify and grow within the contract development and manufacturing industry in North America.
  • The multiphase initiative aims to establish a facility at the 2070 Hadwen site within the Sheridan Research Park campus in Mississauga, ON, Canada.
  • The $6.3M investment by Eurofins CDMO Alphora is supported by a $2.5M grant from the Ontario Government through the Ontario Together Fund (OTF).
  • Further, Eurofins CDMO Alphora’s existing API and HPAPI expertise in linker and warhead development and manufacturing will help support clients with antibody drug conjugate candidates.

Eurofins CDMO Alphora Inc. (Canada) Announces the Relocation and Expansion of its Analytical Services and Research & Development Laboratories to New Campus Hosting all Biopharmaceutical Activities

Retrieved on: 
Wednesday, January 11, 2023
Other Health, Software, Research, Pharmaceutical, Data Management, Apps, Applications, Technology, Health Technology, Science, Biotechnology, Other Science, Health, Process, API, Bruker, Laboratory, Hertz, Hadwen Arboretum, Growth, Education, Communities and Justice Directorates, NMR, CDMO, Multimedia, GMP, Fine chemical

Eurofins CDMO Alphora Inc. is pleased to announce the relocation and expansion of its API development laboratories from 2395 Speakman Drive to its new, owned facility at 2070 Hadwen Road, located within the Sheridan Research Park in Mississauga, Ontario, Canada.

Key Points: 
  • Eurofins CDMO Alphora Inc. is pleased to announce the relocation and expansion of its API development laboratories from 2395 Speakman Drive to its new, owned facility at 2070 Hadwen Road, located within the Sheridan Research Park in Mississauga, Ontario, Canada.
  • View the full release here: https://www.businesswire.com/news/home/20230111005622/en/
    This 56,000 square foot building is the new home of Eurofins CDMO Alphora Inc’s API process R&D activity, solid-state R&D activity and its analytical services team.
  • The campus is also within 2.5 km of Eurofins CDMO Alphora Inc.’s existing API production facility.
  • This latest addition is another important step towards Eurofins CDMO Alphora Inc’s’ vision to build out its Sheridan Research Park campus with additional capacity and technologies in CDMO and biopharmaceutical services.